Piper Jaffray Cuts Price Target on Derma Sciences (DSCI) Following Mixed 3Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Derma Sciences Reports Third Quarter 2015 Financial Results
November 9, 2015 7:30 AM ESTNet Sales Increase 10% and Advanced Wound Care Sales Increase 20%
Conference call begins at 10:00 a.m. Eastern time today
PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and nine months ended September 30, 2015.
Financial highlights of the third quarter of 2015 include (all comparisons are with the third quarter of 2014):
Advanced Wound Care (AWC) net sales increased 19.8% to $11.3 million, or 21.0%... More